RE:Split the company?
thadeush wrote:
probably premature at this point, but assuming (like we all are) the bladder cancer treatment gets the results we expect, would it be smart for TLT to split the cancer treatment part of the company and the vaccine part? Just thinking out loud, but with laser therapy and cancer treatment and vaccine/virus treatment TLT may be getting a bit confusing for the market. It also might maximize profits as each part has incredible potential on its own. Thoughts? (sorry if this has already been discussed)
If we are still independent, any split-up makes the most sense imo once/if we obtain regulatory approvals on both the cancer & vaccine or antiviral fronts....two different markets that requires different strategies/management/capital allocation. Such a split would not only allow for a more focused/targeted approach to help maximize profits, but it also allows for a potential spinoff (if needed) of the division that is considered to have the least potential or value. JMO. Good luck